Navigation Links
Biotech drug causing anemia-EPREX

EPREX, a version of the human recombinant "erythropoietin", a genetically engineered drug, has recently been found to cause a potentially life-threatening anaemia among patients who have been administered with this drug. This drug introduced in the late 1980s and is used to treat patients with kidney disease. //The disease, called Pure Red Cell Aphasia or PRCA usually occurs in vanishingly small number of people and patients affected with this disease need regular blood transfusions. PRCA, though linked to disease of the thymus gland, some viruses and other auto-immune diseases, has never been linked to kidney diseases or drugs used to treat it, till recently.

A special session on the problem was chaired by Dr. Richard Glassock, a kidney specialist at the annual meeting of the American Society of Nephrology, who stated that there have been more than 150 cases of PRCA, which indicates a hundredfold increase over the usual rate. It has also been found that almost all patients who were attacked by this disease were those who were injected the drug under the skin rather than into a vein. However the reason as to why this is happening is not very clear. The German medical professor Eberhard Ritz, who co-chaired the session, said that the answer to this mystery lies in the way Eprex is formulated and not in the drug itself.

French physician Jerome Rossert, one of the first to report this mystery says, its link to method of injection is puzzling, since the number of PRCA cases in France is 33 while Germany reported only 3 cases, in spite of both nations have almost the same no. of kidney patients who inject the drug under the skin. He was however convinced about the safety of human recombinant erythropoietin, though he recommended caution in the use of biotech drugs. The disease, says Dr. Glassock,though debilitating, is curable through a kidney transplant.


'"/>




Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. Biologicals Transfer Proposal between US and Indian Biotechnology
7. Vical Biotech and NIH jointly develops HIV vaccine
8. Biotechnology Initiatives Planned In Hyderabad
9. Biotech Osiris to go public
10. Western Region Tops in Indian Biotech Growth
11. Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech drug causing anemia EPREX

(Date:8/2/2015)... Ky. (PRWEB) , ... August 03, 2015 , ... A ... recurrence of some childhood cancers. The study is led by Kenneth G. Lucas, ... the University of Louisville in collaboration with colleagues at Kosair Children’s Hospital ...
(Date:8/1/2015)... (PRWEB) , ... August 02, 2015 , ... AlignLife ... which will help the continuity of care for patients at this natural health care ... the unknown," Clinic Director Mary Heal said. "Heather's role is vital to our approach ...
(Date:8/1/2015)... Humble, TX (PRWEB) , ... August 01, 2015 , ... ... common concern among both men and women often causing pain and discomfort. Those who ... to this circulatory problem, and Northeast Houston Vein Center is doing what it can ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... ... Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & ... it into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical ...
(Date:8/1/2015)... ... 2015 , ... “ reTXT ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... edit and delete any message including ones already sent. , While text messaging has ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2
... Senate to Introduce and Pass an Identical Bill, ... of Representatives for passing H.R. 1943, The Stop AIDS,in ... by Rep. Maxine Waters,(D-CA) in April would provide routine ... release from federal prisons and allow,inmates to request an ...
... found significant improvement in symptoms and productivity , , TUESDAY, ... who participated in a workplace program that used a ... improvement in their symptoms as well as greater productivity. ... in the Sept. 26 issue of the Journal ...
... Boise,s Leadership in the ... Premium and Specialty Papers Market, BENSENVILLE, Ill., Sept. ... announced that Boise(R) BEWARE(TM), an,anti-copy/anti-scan paper is in compliance with ... legislation,will go into affect on October 1, 2007. Boise(R) ...
... 25 Experts in health care and,technology investment ... technology-based economic growth in Ohio today at the ... These experts will help,shape Ohio,s future as it ... environment for the State of Ohio is changing," ...
... an eating disorder, it is not known whether there are ... Now, a new study finds that women with anorexia ... of the brain that is important for recognizing taste ... University of California, San Diego researchers currently on line in ...
... MANCHESTER, N.H., Sept. 25 Presidential,candidate Senator John ... cost-effective approach towards stopping HIV/AIDS in the US ... address violence against,women and to provide reproductive health ... ideas in Senator Edwards, plan,especially his proposal on ...
Cached Medicine News:Health News:House of Representatives Passes Stop AIDS in Prison Act of 2007 2Health News:Treatment Programs Benefit Depressed Workers 2Health News:Treatment Programs Benefit Depressed Workers 3Health News:Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 3Health News:Sense of taste different in women with anorexia nervosa 2Health News:Exciting New Plan from John Edwards on AIDS; Plan is 'Bold and Achievable,' say New Hampshire Activists 2
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
(Date:7/31/2015)... TAMPA, Fla. , July 31, 2015 /PRNewswire/ ... announced today that it has made a structured ... -based company specializing in milling, micronization and ... investment will help grow Powdersize,s business while simultaneously ... solutions to Xcelience,s portfolio of capabilities. ...
(Date:7/31/2015)... and SAN DIEGO , ... its parent company Eisai Co., Ltd. (Headquarters: ... , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Helen Torley , "NASDAQ: HALO") have signed a ... name: Halaven ® , "eribulin") in combination with Halozyme,s ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... 22 Xoft, makers of Electronic Brachytherapy systems ... integration of its Axxent® Electronic Brachytherapy System at the ... fully comprehensive breast center exclusively dedicated to the prevention, ... Lotus Breast Center is the first comprehensive breast center ...
... Baxano, Inc. ( www.baxano.com ) today announced the closing ... funding, led by new investor CMEA Capital.   Funds were also ... and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny ... , ...
Cached Medicine Technology:Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 3Baxano, Inc. Announces Close of $30 Million Series C Funding 2
... in high performance ultrasound design provides ... echocardiography. Echocardiography imaging requires superior spatial ... Doppler performance. The Terason Echo Ultrasound ... Architecture, delivers a compact imaging platform ...
... the first intra-operative fluorescent imaging system ... the location of the coronary arteries ... coronary artery bypass procedures. ,The patented ... to view, record, replay, print, and ...
... the ingestible SmartPill pH.p Capsule passes through the ... power RF carrier frequencies to the SmartPill Data ... is worn by the patient (supported by either ... records pressure, temperature and pH measurement data, and ...
... light source offers the industry standard high intensity ... at a lower price. A universal turret on ... be used with Olympus, Storz, ACMI/Circon and Wolf ... and re-settable bulb timer. The White Sun will ...
Medicine Products: